Cite Filings / ACAD / 0001967940-26-000042
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

ACADIA PHARMACEUTICALS INC · Filed 2026-08-05 · Acc 0001967940-26-000042

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-08-07 4 EVP, CHIEF FINANCIAL OFFICER sold 20,141 shares at an average $29.16 ($587,242)
  • 2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-08-05 144 Sale of Securities
  • 2026-08-05 10-Q Quarterly Report
  • 2026-08-04 8-K Results of operations
  • 2026-07-31 4 EVP, Head of Research & Dev sold 16,558 shares at an average $26.13 ($432,663)
  • 2026-06-26 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…